A significant breakthrough in cancer investigation is emerging with the use of mini-antibodies to reactivate mutated p53. This essential cancer suppressor protein is frequently inactivated in several types of tumors, https://directmysocial.com/story6742001/nanobodies-restore-tumor-suppressor-p53-the-potential-approach-for-tumor-management